carrier protein


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

carrier protein

[′kar·ē·ər ‚prō‚tēn]
(cell and molecular biology)
A membrane protein that transports a specific solute across the cell membrane by binding to the solute on one side of the membrane and then releasing it on the other.
References in periodicals archive ?
Since very low density lipoproteins are circulating in lesser amounts therefore, the excess of their carrier proteins apoprotein Bs are degraded in liver).
Sfp, the Ppant-transferase [25], is capable of converting the aryl carrier protein (ArCP) domain of DhbB in vitro from the inactive apo form to the HS-Ppant holo form.
6) This is a significant number on its own, but the situation may be even worse when accounting for the fact that the majority of the hormone is bound to carrier proteins including sex hormone binding globulin (SHBG) and albumin and, as such, may not be available for tissues to use.
The role of tandem acyl carrier protein domains in polyunsaturated fatty acid biosynthesis.
Soybean genomic SACPDs were amplified with oligonucleotide primers 5'GCGCCTTACATCACATAC 3'-forward and 5'GCTGCCCCTAACTGC 3'-reverse that were based on the GenBank mRNA sequence (accession number L34346) for a Glycine max, soluble stearoyl-acyl carrier protein desaturase (SACPD).
Conjugate vaccines are produced by linking a bacterial sugar antigen to a carrier protein.
Payne while at Wake Forest Baptist Medical Center, CTI-1601 utilises a carrier protein to deliver frataxin, the deficient protein in Friedreich's Ataxia, to the mitochondria where researchers believe it is processed to mature frataxin and becomes active in mitochondrial metabolism.
The oligosaccharide will be subjected to bioconjugation with a CRM197 carrier protein to produce conjugate vaccine candidate.
Washington, Dec 05 ( ANI ): A research team has found a way to stabilize hemoglobin, the oxygen carrier protein in the blood, a discovery that could lead to the development of stable vaccines and affordable artificial blood substitutes.
The vaccine, Menveo, contains Neisseria meningitidis serotypes A, C, Y, and W135 and is conjugated with the carrier protein cross-reactive material 197 (MenACWY-CRM).
Both Prevnar 13 and Prevnar use CRM(197), an immunological carrier protein with a 20-year history of use in pediatric vaccines.
One hypothesis that has been proposed for inadequate immunogenicity in conjugate vaccines is carrier-induced epitope suppression, where the immune response is directed against the carrier protein and the response to the polysaccharide is suppressed.